Degarelix: a guide to its use in advanced prostate cancer

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.28, Iss.5, 2012-05, pp. : 6-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Degarelix: a guide to its use in advanced prostate cancer

Drugs & Therapy Perspectives, Vol. 26, Iss. 3, 2010-03 ,pp. : 6-8

Adis International

Access to resources Recommend Favorite

Triptorelin embonate (6-month formulation): a guide to its use in advanced prostate cancer

Drugs & Therapy Perspectives, Vol. 26, Iss. 6, 2010-06 ,pp. : 5-7

Adis International

Access to resources Recommend Favorite

Cost-effectiveness analysis comparing degarelix with leuprolide in hormonal therapy for patients with locally advanced prostate cancer

By Hatoum Hind T Crawford E David Nielsen Sandy Kildegaard Lin Swu-Jane Marshall Dennis C

Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 13, Iss. 2, 2013-04 ,pp. : 261-270

Informa Healthcare

Access to resources Recommend Favorite

Abiraterone Acetate: A Guide to Its Use in Metastatic Castration-Resistant Prostate Cancer

By Scott Lesley J. Yang Lily P.H. Lyseng-Williamson Katherine A.

Drugs & Aging, Vol. 29, Iss. 3, 2012-03 ,pp. : 243-248

Adis International

Access to resources Recommend Favorite

Degarelix less costly than goserelin for prostate cancer

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 642, 2011-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite